tiprankstipranks
Trending News
More News >
Pure Bioscience (PURE)
OTHER OTC:PURE
US Market

Pure Bioscience (PURE) Financial Statements

Compare
44 Followers

Pure Bioscience Financial Overview

Pure Bioscience's market cap is currently $5.20M. The company's EPS TTM is $-0.004; its P/E ratio is -2.37; Pure Bioscience is scheduled to report earnings on December 15, 2025, and the estimated EPS forecast is $―. See an overview of income statement, balance sheet, and cash flow financials.
Dec 25Dec 24Dec 23Dec 22Dec 21
Income Statement
Total Revenue$ 2.20B$ 1.96M$ 1.88M$ 1.85M$ 3.93M
Gross Profit$ 1.30B$ 1.15M$ 971.00K$ 1.00M$ 2.08M
Operating Income$ -2.27M$ -3.13M$ -3.94M$ -3.42M$ -2.31M
EBITDA$ -2.10M$ -3.05M$ -3.83M$ -3.27M$ -2.14M
Net Income$ -2.40M$ -3.35M$ -3.96M$ -3.50M$ -2.32M
Balance Sheet
Cash & Short-Term Investments$ 334.00M$ 349.00K$ 1.09M$ 3.39M$ 2.39M
Total Assets$ 1.06B$ 818.00K$ 1.82M$ 4.48M$ 4.30M
Total Debt$ 5.24B$ 2.95M$ 1.02M$ 0.00$ 239.00K
Net Debt$ 4.90B$ 2.60M$ -74.00K$ -3.39M$ -2.15M
Total Liabilities$ 6.17B$ 3.68M$ 1.55M$ 575.00K$ 970.00K
Stockholders' Equity$ -5.12B$ -2.86M$ 272.00K$ 3.91M$ 3.33M
Cash Flow
Free Cash Flow$ -2.02B$ -2.53M$ -3.31M$ -2.50M$ -1.69M
Operating Cash Flow$ -2.02B$ -2.53M$ -3.28M$ -2.42M$ -1.17M
Investing Cash Flow$ 0.00$ 0.00$ -33.00K$ -81.00K$ -521.00K
Financing Cash Flow$ 2.00B$ 1.78M$ 1.01M$ 3.50M$ 239.00K
Currency in USD

Pure Bioscience Earnings and Revenue History

Pure Bioscience Debt to Assets

Pure Bioscience Cash Flow

Pure Bioscience Forecast EPS vs Actual EPS